GGrantIndex
← Leaderboards

Maki Nakayama

University Of Colorado Denver

$6,654,561
Attributed
$8,190,172
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,190,172 · 8

By mechanism

R01$5,971,686 · 2
P30$1,126,261 · 3
R00$742,020 · 1
R56$194,375 · 1
K99$155,830 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Pancreas

Research focus

PancreasIsletAntigensInsulin-Dependent Diabetes MellitusInsulinImmuneCellsImmunotherapyPreventT-Cell ReceptorBasePeptidesT-LymphocyteSpecificityDiabetes MellitusResponsePathogenesisIslets Of LangerhansEpitopesAutoantibodiesTissuesMolecularPathway InteractionsAutoimmunity

Grant awards (26)

Islet-specific CD8 T cells in the pathogenesis of type 1 diabetes$745,583
R01 · FY2025 · DK · contact PI
Tissue Procurement, Processing and Phenotyping Core$223,818
P30 · FY2025 · DK · contact PI
The Antigen Repertoire of CD4 T cells from Pancreatic Islets$446,132
R01 · FY2024 · DK · contact PI
Tissue Procurement and Processing Core$174,192
P30 · FY2024 · DK · contact PI
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood$532,816
R01 · FY2023 · DK · contact PI
The Antigen Repertoire of CD4 T cells from Pancreatic Islets$472,396
R01 · FY2023 · DK · contact PI
Tissue Procurement and Processing Core$177,434
P30 · FY2023 · DK · contact PI
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood$532,816
R01 · FY2022 · DK · contact PI
The Antigen Repertoire of CD4 T cells from Pancreatic Islets$493,725
R01 · FY2022 · DK · contact PI
Tissue Procurement and Processing Core$180,581
P30 · FY2022 · DK · contact PI
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood$532,816
R01 · FY2021 · DK · contact PI
Tissue Procurement and Processing Core$183,636
P30 · FY2021 · DK · contact PI
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood$532,816
R01 · FY2020 · DK · contact PI
Tissue Procurement and Processing Core$186,600
P30 · FY2020 · DK · contact PI
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to blood$194,375
R56 · FY2019 · DK · contact PI
Molecular Dissection of Insulin Targeting in Anti-Islet Autoimmunity$338,213
R01 · FY2017 · DK · contact PI
Molecular Dissection of Insulin Targeting in Anti-Islet Autoimmunity$338,213
R01 · FY2016 · DK · contact PI
Molecular Dissection of Insulin Targeting in Anti-Islet Autoimmunity$338,213
R01 · FY2015 · DK · contact PI
Molecular Dissection of Insulin Targeting in Anti-Islet Autoimmunity$337,125
R01 · FY2014 · DK · contact PI
Molecular Dissection of Insulin Targeting in Anti-Islet Autoimmunity$330,822
R01 · FY2013 · DK · contact PI
STRUCTURE PEPTIDE/CONSERVED T CELL RECEPTOR DETERMINING DIABETES$246,511
R00 · FY2012 · DK · contact PI
STRUCTURE PEPTIDE/CONSERVED T CELL RECEPTOR DETERMINING DIABETES$246,509
R00 · FY2011 · DK · contact PI
STRUCTURE PEPTIDE/CONSERVED T CELL RECEPTOR DETERMINING DIABETES$249,000
R00 · FY2010 · DK · contact PI
Structure Peptide/Conserved T-cell Receptor Determining Diabetes$78,200
K99 · FY2009 · DK · contact PI
Structure Peptide/Conserved T-cell Receptor Determining Diabetes$1,080
K99 · FY2009 · DK · contact PI
Structure Peptide/Conserved T-cell Receptor Determining Diabetes$76,550
K99 · FY2008 · DK · contact PI